devices that integrate glp-1 schedules and glucose data Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics

Because individual health factors vary, patients should inform their provider about all medications, supplements, and medical conditions

Notably, regain occurred despite continuation of structured lifestyle interventions in most studies, underscoring discontinuation itself as a critical relapse risk point

The small amounts in compounded tirzepatide pose essentially no risk

Pregnant and breastfeeding individuals should avoid supplementation without explicit provider approval due to limited safety data in these populations

Gan X, Qiao S, Liang Y, Li K, Xu H (2024) Ascorbate-glutathione cycle and thioredoxin system are involved in nitric oxide alleviating excess nitrate stress in tomato seedlings